Apogee Therapeutics, Inc. clinical trials
Acquired by AbbVie, Sep 3, 2026 · source ↗
The registry lists 4 studies whose lead sponsor is Apogee Therapeutics, Inc.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.
Before and after it joined AbbVie
- First submitted before Apogee Therapeutics, Inc. became part of AbbVie
- 4
- First submitted after Apogee Therapeutics, Inc. became part of AbbVie
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Apogee Therapeutics, Inc.4 studies
Something wrong with this grouping? Tell us on the AbbVie page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All AbbVie studies →
- A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisRecruitingNCT07003425Phase 2
Sponsor listed in the registry: Apogee Therapeutics, Inc. · First submitted before Apogee Therapeutics, Inc. became part of AbbVie
- A Study Evaluating APG777 in Atopic DermatitisActive, not recruitingNCT06395948Phase 2
Sponsor listed in the registry: Apogee Therapeutics, Inc. · First submitted before Apogee Therapeutics, Inc. became part of AbbVie
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With AsthmaActive, not recruitingNCT06920901Phase 1
Sponsor listed in the registry: Apogee Therapeutics, Inc. · First submitted before Apogee Therapeutics, Inc. became part of AbbVie
- An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic DermatitisActive, not recruitingNCT07027527Phase 1
Sponsor listed in the registry: Apogee Therapeutics, Inc. · First submitted before Apogee Therapeutics, Inc. became part of AbbVie